Simcere Pharmaceutical (NYSE:SCR): Q4 EPS of $0.12 beats by $0.07. Revenue of $81.2M (-9.2% Y/Y)...

Simcere Pharmaceutical (NYSE:SCR): Q4 EPS of $0.12 beats by $0.07. Revenue of $81.2M (-9.2% Y/Y) misses by $6M. (PR)